کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2567002 1128303 2014 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Omalizumab management beyond clinical trials: The added value of a network model
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پزشکی ریوی و تنفسی
پیش نمایش صفحه اول مقاله
Omalizumab management beyond clinical trials: The added value of a network model
چکیده انگلیسی

BackgroundOmalizumab is effective and safe in severe allergic asthma. Few data are available about its impact on lung function and on asthma comorbidities, long-term follow-up of treated patients, adherence, non-responders profile, and optimal treatment duration.ObjectiveWe aimed at evaluating omalizumab-related clinical outcomes and unmet needs in a real-life setting.MethodsWe created a collaborative network (NEONet – North East Omalizumab Network) involving 9 Allergy and Respiratory referral centres for severe asthma placed in the North-East of Italy. Patients' data were entered into a common study database shared by all the participating physicians. A preliminary retrospective analysis was performed.ResultsPatients come from a common well-defined geographical and environmental district providing a homogeneous population sample. A moderate but statistically significant improvement of the FEV1, and an increasing proportion of exacerbations-free patients were observed since the treatment start. These findings were independent of the baseline severity of bronchial obstruction. A positive impact of omalizumab on rhinitis in patients with both asthma and rhinitis was detected. Moreover the efficacy of omalizumab on asthma seemed not to be affected by the baseline severity of rhinitis.ConclusionOur retrospective analysis represents a preliminary report from the NEONet activity. It confirmed omalizumab efficacy and provided some new insights about its impact on lung function and on comorbid rhinitis. The network approach, under a prospective view, allows creating a large uniform database, by means of a standardized shared tool for data collecting, and joining a multidisciplinary expertise.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Pulmonary Pharmacology & Therapeutics - Volume 29, Issue 1, October 2014, Pages 74–79
نویسندگان
, , , , , , , , , , ,